Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control

Purpose of review Sexually transmitted infections (STIs) remain a major global public health issue, with more than 448 million incident bacterial infections each year. We review recent advances in STI point-of-care (POC) testing and implications for STI prevention and control. Recent findings Accurate immunochromatographic assays to detect HIV, hepatitis C virus (HCV) and syphilis antibodies have made home or supervised self-testing possible. Several studies have demonstrated feasibility and excellent test characteristics for HIV, HCV and syphilis POC tests. Rapid oral HIV tests are now available for purchase at retail sites across the United States. Combined HIV and syphilis tests using a single finger prick blood sample are under evaluation. Summary Oral POC STI tests with comparable performance to blood-based POC tests are available for self-testing. POC tests can expand screening, improve syndromic management and reduce loss to follow up. POC STI tests have the potential to facilitate prompt treatment and partner services. POC STI tests create opportunities for new social and financial models of community-based testing services. Increasing equity and access to testing will create challenges in linkage to care, quality assurance, partner services and surveillance. These important developments warrant research to understand appropriate contexts for implementation.

[1]  K. Lewandrowski,et al.  Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. , 2011, Archives of pathology & laboratory medicine.

[2]  N. Engel,et al.  Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries , 2012, PLoS medicine.

[3]  Rosanna W. Peeling,et al.  Social Entrepreneurship for Sexual Health (SESH): A New Approach for Enabling Delivery of Sexual Health Services among Most-at-Risk Populations , 2012, PLoS medicine.

[4]  K. Konty,et al.  Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations. , 2011, American journal of public health.

[5]  K. Pattanapanyasat,et al.  Performance Evaluation of the Alere PIMA CD4 Test for Monitoring HIV-Infected Individuals in Resource-Constrained Settings , 2011, Journal of acquired immune deficiency syndromes.

[6]  S. Zakaria,et al.  Evaluation of BV(®) Blue Test Kit for the diagnosis of bacterial vaginosis. , 2011, Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives.

[7]  J. Wasserheit,et al.  The emerging threat of untreatable gonococcal infection. , 2012, The New England journal of medicine.

[8]  S. Morré,et al.  Point-of-Care Test for Detection of Urogenital Chlamydia in Women Shows Low Sensitivity. A Performance Evaluation Study in Two Clinics in Suriname , 2012, PloS one.

[9]  R. Elghanian,et al.  p24 Antigen Rapid Test for Diagnosis of Acute Pediatric HIV Infection , 2010, Journal of acquired immune deficiency syndromes.

[10]  Sarah J. Erickson,et al.  Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. , 2012, American journal of public health.

[11]  P. Sullivan,et al.  Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  N. French,et al.  The Uptake and Accuracy of Oral Kits for HIV Self-Testing in High HIV Prevalence Setting: A Cross-Sectional Feasibility Study in Blantyre, Malawi , 2011, PLoS medicine.

[13]  William M. Lee,et al.  Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid. , 2011, Journal of virological methods.

[14]  M. Pai,et al.  Tuberculosis control: business models for the private sector. , 2012, The Lancet. Infectious diseases.

[15]  Aydogan Ozcan,et al.  Integrated rapid-diagnostic-test reader platform on a cellphone. , 2012, Lab on a chip.

[16]  Lawrence Joseph,et al.  Head-to-head comparison of accuracy of a rapid point-of-care HIV test with oral versus whole-blood specimens: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[17]  M. Ashton,et al.  Novel Point-of-Care Test for Simultaneous Detection of Nontreponemal and Treponemal Antibodies in Patients with Syphilis , 2010, Journal of Clinical Microbiology.

[18]  Myron S. Cohen,et al.  A Twin Response to Twin Epidemics: Integrated HIV/Syphilis Testing at STI Clinics in South China , 2011, Journal of acquired immune deficiency syndromes.

[19]  M. Schito,et al.  Perspectives on introduction and implementation of new point-of-care diagnostic tests. , 2012, The Journal of infectious diseases.

[20]  William C Miller,et al.  Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. , 2012, The Journal of infectious diseases.

[21]  Y. K. Cheung,et al.  1 Supplementary Information for : Microfluidics-based diagnostics of infectious diseases in the developing world , 2011 .

[22]  E. Karita,et al.  Failure of A Novel, Rapid Antigen and Antibody Combination Test to Detect Antigen-Positive HIV Infection in African Adults with Early HIV Infection , 2012, PloS one.

[23]  Rosanna W. Peeling,et al.  Point-of-Care Tests to Strengthen Health Systems and Save Newborn Lives: The Case of Syphilis , 2012, PLoS medicine.

[24]  B. Kuehn CDC pilot program will offer free rapid HIV tests through pharmacies. , 2012, JAMA.

[25]  R. Peeling Applying new technologies for diagnosing sexually transmitted infections in resource-poor settings , 2011, Sexually Transmitted Infections.

[26]  S. Peel,et al.  Laboratory evaluation of rapid test kits to detect hepatitis C antibody for use in predonation screening in emergency settings , 2013, Transfusion.

[27]  R. Garfein,et al.  Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus. , 2011, The Journal of infectious diseases.

[28]  T. Finlayson,et al.  Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  R. Garfein,et al.  Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  R. Lillis,et al.  Evaluation of the Roche cobas® CT/NG Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male Urine , 2012, Sexually transmitted diseases.

[31]  Curtis Dolezal,et al.  Use of a Rapid HIV Home Test Prevents HIV Exposure in a High Risk Sample of Men Who Have Sex With Men , 2012, AIDS and Behavior.

[32]  Andrew Copas,et al.  Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service , 2012, Sexually Transmitted Infections.

[33]  S. Strasser,et al.  Introduction of Rapid Syphilis Testing Within Prevention of Mother-to-Child Transmission of HIV Programs in Uganda and Zambia: A Field Acceptability and Feasibility Study , 2012, Journal of acquired immune deficiency syndromes.

[34]  F. V. van Tiel,et al.  Alarmingly poor performance in Chlamydia trachomatis point-of-care testing , 2010, Sexually Transmitted Infections.

[35]  B. Castelnuovo,et al.  Evaluation of Portable Point-of-Care CD4 Counter with High Sensitivity for Detecting Patients Eligible for Antiretroviral Therapy , 2012, PloS one.

[36]  B. George,et al.  Introduction of Rapid Tests for Large-Scale Syphilis Screening Among Female, Male, and Transgender Sex Workers in Mumbai, India , 2011, Sexually transmitted diseases.

[37]  A. Samarawickrama,et al.  A laboratory-based evaluation of the BioStar Optical ImmunoAssay point-of-care test for diagnosing Neisseria gonorrhoeae infection. , 2011, Journal of medical microbiology.

[38]  R. Peeling,et al.  Field performance of a rapid point-of-care diagnostic test for antenatal syphilis screening in the Amazon region, Brazil , 2011, International journal of STD & AIDS.

[39]  S. Goldenberg,et al.  Performance of the GeneXpert CT/NG Assay Compared to That of the Aptima AC2 Assay for Detection of Rectal Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Residual Aptima Samples , 2012, Journal of Clinical Microbiology.

[40]  B. Levin,et al.  Use of a Rapid HIV Home Test to Screen Sexual Partners: A Commentary on Ventuneac, Carballo-Diéguez, Leu et al. 2009 , 2011, AIDS and Behavior.

[41]  Paul LaBarre,et al.  Isothermal Amplification Using a Chemical Heating Device for Point-of-Care Detection of HIV-1 , 2012, PloS one.

[42]  Trevor F Peter,et al.  Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study , 2011, The Lancet.